Alzheimer's disease mutations in APP but not gamma-secretase modulators affect epsilon-cleavage-dependent AICD production.

Dimitrov M, Alattia, JR, Lemmin T, Rajwinder L, Fligier A, Houacine J, Hussain I, Radtke F, Dal Peraro M, Beher D, and Fraering PC.
Nat. Commun. 4 (2013), 2246 ff
> Read more

Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400.

Cameron A, Giacomozzi B, Joyce J, Gray A, Graham D, Ousson S, Neny M, Beher D, Carlson G, O'Moore J, Shearman M, Hering H.
FEBS Lett. 2013 Nov; 586 (22): 3722 - 28
> Read more

Substrate determinants in the C99 juxtamembrane domains differentially affect γ-secretase cleavage specificity and modulator pharmacology.

Ousson S, Saric A, Baguet A, Losberger C, Genoud S, Vilbois F, Permanne B, Hussain I, Beher D.
J Neurochem. 125 (2013), 610-619 
> Read more


The role of γ-Secretase Activating Protein, GSAP and imatinib in the regulation of γ-secretase activity and amyloid-β generation.

Hussain I, Fabregue J, Anderes L, Ousson S, Borlat F, Eligert V, Berger S, Dimitrov M, Alattia JR, Fraering PC, Beher D.
J Biol Chem. 2013 Jan ; 288 (4): 2521-31
> Read more


Development and Characterization of a Novel Membrane Assay for Full-Length BACE-1 at pH 6.0.

Saric A, Brügge LZ, Müller-Pompalla D, Rysiok T, Ousson S, Permanne B, Quattropani A, Busch M, Beher D, Hussain I.
J Biomol Screen. 2012 Sep 27. [Epub ahead of print]
> Read more


Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.

Zettl H, Ness J, Hähnke V, Beher D, Jumpertz T, Saric A, Baumann K, Pietrzik CU, Bulic B, Schneider G, Weggen S.
ACS Chem Biol. 2012 Sep 21;7(9): 1488-95.
> Read more


Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease.

Weggen S, Beher D.
Alzheimers Res Ther. 2012 Mar 30;4(2):9
> Read more

Publications